My Lyme Disease Testing Explained

First let's look at the ELISA, then scroll down to see my testing from IgeneX

The problem lies with the CDC standard 41-year old ELISA testing

initially when you go to the Emergency Room or a doctor orders a Lyme Test:

The test below is STANDARD in EVERY HOSPITAL OR DOCTOR OFFICE EVERYWHERE!

The ELISA test leaves out BAND N31 and BAND N34 SO SPECIFIC for LYME; YALE

University/Smith-Kline made the LYMERIX vaccine out of it.

The vaccine made everyone so sick and die; they had to take it off the market. They told the press; THERE WAS

A LACK OF INTEREST IN THE VACCINE....Don't you think if it worked, us SICK people

would WANT a CURE??? Lack of Interest indeed.

~ * ~

Borrelia burgdorferi Antibodies, Total by ELISA (CSF) - ARUP Lab Tests

See what their lab has to say about the ELISA or EIA IN THEIR OWN WORDS...

http://www.arupconsult.com/Topics/InfectiousDz/Bacteria/LymeDisease.html

  Below is from ARUP Labs for the Doctors to consult for treatment guidelines. BOGUS!

  The Physician's Guide to Laboratory Test Selection and Interpretation

Borrelia burgdorferi - Lyme Disease

• Clinical Background
• Tests
• References
• Algorithm

 Lyme Disease Testing Algorithm

Lyme disease is the most common vector-borne disease in the U.S.

Epidemiology

• Gender – M:F; 1:1 except for the presentation of acrodermatitis chronica atrophicans (M<F)
• Transmission – infected Ixodes tick

Organism

• Borrelia burgdorferi
• Member of the Spirochaetales family which also includes Treponema and Leptospira

Risk Factors

• Exposure in regions where deer population is high during the spring or summer
• Northeast or Midwest geographic location

Clinical Presentation

• Centers for Disease Control (CDC) clinical case epidemiologic surveillance criteria for defining Lyme disease
  • Erythema migrans (EM) ≥5 cm in diameter or
  • Laboratory confirmation of infection and at least 1 late manifestation
    • Musculoskeletal manifestation – recurrent, brief attacks of objective joint swelling in 1 or more joints
    • Neurological manifestations
      • Lymphocytic meningitis
      • Cranial neuritis
      • Radiculoneuropathy
      • Encephalomyelitis – requires demonstration of CSF antibody production
      • Cardiovascular manifestations – acute second or third degree arteriovenous (AV) heart block
• Lyme disease stages
  • Stage 1 early localized
    • May begin within hours to several weeks after infection
    • Characterized by erythema migrans (EM) or lymphocytoma (rare in U.S.)
    • Regional adenopathy and/or minor constitutional symptoms
  • Stage 2 early disseminated
    • Occurs weeks to months following the tick bite
    • Characterized by neurologic and cardiac involvement (manifested in 15% and 8% of patients, respectively)
    • Manifestations
      • Fever
      • Myalgias
      • Multiple EM lesions
      • Meningitis
      • Bells Palsy
      • Guillain-Barré-like syndrome
      • Cardiac conduction abnormalities
      • Arthritis
  • Stage 3 late disseminated
    • Can develop within a few weeks to 2 years following infection
    • Symptoms are more severe than early disseminated
    • Characterized by arthritis
      • Occurs in 60% of individuals not effectively treated early in infection
      • Tends to be intermittent, lasting from several days to weeks
    • Late Lyme disease can affect central nervous system
    • Patients may have memory loss, fatigue and polyneuropathy
• Initial symptoms usually appear in late spring/early summer, when ticks are active
• Late manifestations occur anytime

Diagnosis

• Laboratory testing
  • Diagnosis depends on clinical features, combined with available laboratory tests
    • C6 peptide antibodies or Borrelia antibodies by ELISA
  • Refer to the Lyme Disease Testing algorithm
• Current CDC recommendations for serologic diagnosis of Lyme disease
  • Screen with a polyvalent ELISA test
  • Confirm equivocal and positive results with Western Blot
  • Refer to Lyme Disease Testing algorithm
• Co- and triple-infections by parasites that cause babesiosis and human granulocytic ehrlichiosis may occur
  • Serologic testing specific for these agents is recommended
  • Co- and triple-infections by parasites that cause babesiosis and human granulocytic ehrlichiosis may occur; serological testing specific for these agents is recommended

Treatment

• Lyme disease, caught early, is easily treated
  • Treatment prevents progression to chronic stage
  • Severe, long-term effects occur in <10% of untreated patients
• If known tick bite and erythema migrans present, proceed with treatment; testing is not necessary

Then i wised up and got informed and took a more specific, newer test by IgeneX Labs in California

I knew, i had this terrible disease....i had 29 symptoms, and i knew i was real sick.

Can you really see what is happening to everyone here? Allen Steere (CDC) wants to keep this

disease in the Rheumatology department, as a arthritis of the knee....when really it's a relapsing fever

and should be in the Neurology department. That is why the ELISA standard was raised so high at the

Dearborn Conference in 1994 to .99  to be equivocal

or positive, and it misses SO MANY PEOPLE who are really positive.

 It is terrible what is happening. We should not have to fight for our health!

PLEASE don't let this happen to you, or someone you love.

If you even think you might have Lyme, seek a group and

they will help you find a LLMD in your area.